Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement, Common Stock Purchase Agreement (Remark Media, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 840,461 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement, Common Stock Purchase Agreement (Ipass Inc)
Issuance of Commitment Shares. In connection with Upon the Commencementexecution hereof, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 600,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirementlegend.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement, Common Stock Purchase Agreement (Dynavax Technologies Corp)
Issuance of Commitment Shares. In connection with Promptly following the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 842,696 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Caladrius Biosciences, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 1,449,275 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 2,374,545 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Remark Holdings, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 6,250,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Innovation Pharmaceuticals Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 255,161 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Apricus Biosciences, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 3,086,420 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirementlegend.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Beacon Power Corp)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 150,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 709,103 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 320,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Cancer Genetics, Inc)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 160,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 34,762 shares of Common Stock (the “Commitment Shares”). ) The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Recro Pharma, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 213,574 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Remark Holdings, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 1,725,490 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 880,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Westwater Resources, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 363,636 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirementlegend.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 shares of 171,428 Common Stock Shares (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Share Purchase Agreement (Aptose Biosciences Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 shares of Common Stock 612,520 Ordinary Shares (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Ordinary Shares Purchase Agreement (Intec Pharma Ltd.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 shares of 170,261 Common Stock Shares (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Share Purchase Agreement (Aptose Biosciences Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 1,518,987 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Apricus Biosciences, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 300,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Innovation Pharmaceuticals Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 104,167 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Entasis Therapeutics Holdings Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 164,835 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 shares of 973,000 Common Stock Shares (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Share Purchase Agreement (Titan Medical Inc)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 700,000 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Cerulean Pharma Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 304,457 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement..
Appears in 1 contract
Issuance of Commitment Shares. In connection with Promptly following the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 364,837 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 297,030 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirementlegend.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Transwitch Corp /De)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 33,040 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Recro Pharma, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 166,105 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Cyclacel Pharmaceuticals, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 345,357 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirement.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Marker Therapeutics, Inc.)
Issuance of Commitment Shares. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer entering into this Agreement 151,515 144,927 shares of Common Stock (the “Commitment Shares”). The Commitment Shares shall be issued without any restrictive legend whatsoever or prior sale requirementlegend.
Appears in 1 contract